CORTINOVIS, DIEGO LUIGI

CORTINOVIS, DIEGO LUIGI  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 20 di 175 (tempo di esecuzione: 0.047 secondi).
Titolo Tipologia Data di pubblicazione Autori File
A cross-sectional analysis of treatment patterns in small-cell lung cancer in five European countries 01 - Articolo su rivista 2024 Cortinovis, D +
Economic assessment of NGS testing workflow for NSCLC in a healthcare setting 01 - Articolo su rivista 2024 Seminati, DavideL'Imperio, VincenzoCasati, GabrielePilla, DanielaCortinovis, Diego LuigiBono, FrancescaPagni, Fabio +
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients 01 - Articolo su rivista 2024 Villa, MatteoMalighetti, FedericaSharma, Geeta G.Manfroni, ChiaraFontana, DilettaCordani, NicolettaMeneveri, RaffaellaPiazza, RoccoPagni, FabioCortinovis, DiegoMologni, Luca +
Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma 01 - Articolo su rivista 2024 Cortinovis, Diego +
Proteolysis Targeting Chimera Agents (PROTACs): New Hope for Overcoming the Resistance Mechanisms in Oncogene-Addicted Non-Small Cell Lung Cancer 01 - Articolo su rivista 2024 Cordani N.Nova D.Sala L.Abbate M. I.Cortinovis D. L. +
Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed 01 - Articolo su rivista 2024 Cortinovis, Diego Luigi +
Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-world data from the Italian expanded access program 01 - Articolo su rivista 2024 Cortinovis, Diego +
The biomarkers ATLAS: An audit on 1100 non-small cell lung cancer from an Italian knowledge-based database 01 - Articolo su rivista 2024 Cortinovis, DiegoPagni, Fabio +
An Overview of PARP Resistance in Ovarian Cancer from a Molecular and Clinical Perspective 01 - Articolo su rivista 2023 Cordani N.Bianchi T.Cortinovis D. L.Cazzaniga M. E.Lissoni A. A.Landoni F. +
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study 01 - Articolo su rivista 2023 Cortinovis, D +
Novel Therapeutic Options for Small Cell Lung Cancer 01 - Articolo su rivista 2023 Abbate, MIBianchi, SPCortinovis, DL +
Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer 01 - Articolo su rivista 2023 Diego Cortinovis +
Sharing Experience with Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors in Lung Cancer: An Italian Expert Panel Discussion 01 - Articolo su rivista 2023 Cortinovis, DL +
A Cast of Shadow on Postoperative Radiotherapy for pIIIA-N2 Non-Small Cell Lung Cancer? 01 - Articolo su rivista 2022 Arcangeli, SCortinovis, D +
A primarily clinician's responsibility 01 - Articolo su rivista 2022 Biondi A.Cortinovis D. +
Clinical treatment of cholangiocarcinoma: an updated comprehensive review 01 - Articolo su rivista 2022 Laffusa, AliceScaravaglio, MikiCristoferi, LauraCiaccio, AntonioCortinovis, Diego LuigiInvernizzi, PietroMassironi, Sara +
Detection of ALK fusion variants by RNA-based NGS and clinical outcome correlation in NSCLC patients treated with ALK-TKI sequences 01 - Articolo su rivista 2022 Cortinovis D +
Durvalumab After Sequential Chemoradiotherapy in Stage III, Unresectable NSCLC: The Phase 2 PACIFIC-6 Trial 01 - Articolo su rivista 2022 Cortinovis D +
Epidermal growth factor receptor exon 20 insertion variants in non-small cell lung cancer patients 01 - Articolo su rivista 2022 Cortinovis D.Seminati D.Pagni F. +
Evaluating the impact of chemotherapy-induced nausea and vomiting on daily functioning in patients receiving dexamethasone-sparing antiemetic regimens with NEPA (netupitant/palonosetron) in the cisplatin setting: results from a randomized phase 3 study 01 - Articolo su rivista 2022 Cortinovis D +